Frauke Bentzien
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Reproductive Medicine top 2%
- Endometriosis Research and Treatment
Papers in
-
- Endometriosis Research and Treatment 3
-
- Liver physiology and pathology 2
- Co-authors
- F. Michael YakesAlison JolyStefan EngstPeiwen YuFawn QianJenny TanToshihiro YamaguchiFelix Chu
- Journals
- Molecular Cancer Therapeutics (1 paper)Molecular Human Reproduction (1 paper)Fertility and Sterility (1 paper)Journal of Clinical Oncology (1 paper)Investigative Ophthalmology & Visual Science (1 paper)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Frauke Bentzien
12 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 372
- Reproductive Medicine 288
- Oncology 665
- Obstetrics and Gynecology 166
- Cancer Research 298
Countries citing papers authored by Frauke Bentzien
This map shows the geographic impact of Frauke Bentzien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frauke Bentzien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frauke Bentzien more than expected).
Fields of papers citing papers by Frauke Bentzien
This network shows the impact of papers produced by Frauke Bentzien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frauke Bentzien. The network helps show where Frauke Bentzien may publish in the future.
Co-authors
The 25 scholars most cited alongside Frauke Bentzien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 26 | |
| 2 | 2013 | 102 | |
| 3 | 2013 | 1 | |
| 4 | Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth Hit paper breakdown → | 2011 | 1036 |
| 5 | 2009 | 282 | |
| 6 | 2008 | 2 | |
| 7 | 2004 | 52 | |
| 8 | 2001 | 40 | |
| 9 | Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice. | 2001 | 44 |
| 10 | 2000 | 161 | |
| 11 | 1999 | 241 | |
| 12 | 1993 | 112 |
About Frauke Bentzien
Frauke Bentzien is a scholar working on Reproductive Medicine, Hepatology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Cancer Research, having authored 12 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Endometriosis Research and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Liver physiology and pathology (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Pituitary Gland Disorders and Treatments (1 paper). The work is most often cited by research in Hepatology (372 citations), Reproductive Medicine (288 citations), Oncology (665 citations), Obstetrics and Gynecology (166 citations) and Cancer Research (298 citations). Frauke Bentzien has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include F. Michael Yakes, Alison Joly, Stefan Engst, Peiwen Yu, Fawn Qian, Jenny Tan, Toshihiro Yamaguchi, Felix Chu, Belinda Cancilla and Yongchang Shi. Their work appears in journals such as Molecular Cancer Therapeutics, Molecular Human Reproduction, Fertility and Sterility, Journal of Clinical Oncology and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.